We discovered that ELAVL3 is transcriptionally activated by MYCN, and subsequently binds to and stabilizes the mRNA of both MYCN and RICTOR. This interaction gives rise to a positive feedback loop that promotes neuroendocrine differentiation and enhances tumor growth. The gene discussed is ELAVL3; the disease is neoplasm.